Pharmacologic treatments could fill the unmet need for vision correction in presbyopic patients who want to see well without spectacles or contact lenses but do not opt for a surgical solution.
Presbyopia affects more than 1.8 billion people worldwide, including more than an estimated 11 million in the U.S. For those patients who do not want to wear corrective lenses, there is a host of management options, all surgical and all elective: excimer laser ablation, femtosecond laser intrastromal correction, multifocal and accommodating IOLs, and intracorneal inlays.
Some companies are coming (Read more...)
Uncategorized